Docon Technologies, a promoter entity of Thyrocare Technologies, sold 53.32 lakh equity shares for a total consideration of around ₹668 crore.
Docon Technologies, a promoter entity of Thyrocare Technologies, sold 53.32 lakh equity shares for a total consideration of around ₹668 crore.